Miglitol increases energy expenditure by upregulating uncoupling protein 1 of brown adipose tissue and reduces obesity in dietary-induced obese mice

BACKGROUND: Miglitol is an oral anti-diabetic drug that acts by inhibiting carbohydrate absorption in the small intestine. Recent studies have shown that miglitol reduces obesity in humans and rodents. However, its mechanisms have remained unclear. The purpose of this study was to determine whether...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sugimoto, Satoru, Nakajima, Hisakazu, Kodo, Kazuki, Mori, Jun, Matsuo, Kensuke, Kosaka, Kitaro, Aoi, Wataru, Yoshimoto, Kanji, Ikegaya, Hiroshi, Hosoi, Hajime
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3986880/
https://ncbi.nlm.nih.gov/pubmed/24669882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-7075-11-14
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi